Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update | Zendy

Nasser H. Hanna | Zendy; Bryan J. Schneider | Zendy; Sarah Temin | Zendy; Sherman Baker | Zendy; Julie R. Brahmer | Zendy; Peter Ellis | Zendy; Laurie E. Gaspar | Zendy; Rami Y. Haddad | Zendy; Paul J. Hesketh | Zendy; Dharamvir Jain | Zendy; Ishmael Jaiyesimi | Zendy; David H. Johnson | Zendy; Natasha B. Leighl | Zendy; Tanyanika Phillips | Zendy; Gregory J. Riely | Zendy; Andrew Robinson | Zendy; Rafael Rosell | Zendy; Joan H. Schiller | Zendy; Navneet Singh | Zendy; David R. Spigel | Zendy; Janis O. Stabler | Zendy; Joan Tashbar | Zendy; Gregory A. Masters | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Author(s) -

Nasser H. Hanna,

Bryan J. Schneider,

Sarah Temin,

Sherman Baker,

Julie R. Brahmer,

Peter Ellis,

Laurie E. Gaspar,

Rami Y. Haddad,

Paul J. Hesketh,

Dharamvir Jain,

Ishmael Jaiyesimi,

David H. Johnson,

Natasha B. Leighl,

Tanyanika Phillips,

Gregory J. Riely,

Andrew Robinson,

Rafael Rosell,

Joan H. Schiller,

Navneet Singh,

David R. Spigel,

Janis O. Stabler,

Joan Tashbar,

Gregory A. Masters

Publication year - 2020

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.19.03022

Subject(s) - carboplatin , medicine , atezolizumab , pembrolizumab , pemetrexed , bevacizumab , oncology , lung cancer , guideline , crizotinib , cancer , chemotherapy , cisplatin , immunotherapy , pathology , malignant pleural effusion

The aim of this work is to provide evidence-based recommendations updating the 2017 ASCO guideline on systemic therapy for patients with stage IV non-small-cell lung cancer (NSCLC) without driver alterations. A guideline update for patients with stage IV NSCLC with driver alterations will be published separately.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research